These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 2283189
21. Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome. De Maria R, Di Lenarda A, Gavazzi A, Porcu M, Sinagra G, Parolini M, SPIC (Italian Multicenter Cardiomyopathy Study) Group. Ital Heart J; 2001 Feb; 2(2):130-8. PubMed ID: 11256541 [Abstract] [Full Text] [Related]
28. Early changes in longitudinal performance predict future improvement in global left ventricular function during long term beta adrenergic blockade. Andersson B, Waagstein F, Caidahl K, Eurenius I, Täng MS, Wikh R. Heart; 2000 Dec; 84(6):599-605. PubMed ID: 11083735 [Abstract] [Full Text] [Related]
32. Short-term and long-term hemodynamic and clinical effects of metoprolol alone and combined with amlodipine in patients with chronic heart failure. Kukin ML, Freudenberger RS, Mannino MM, Kalman J, Steinmetz M, Buchholz-Varley C, Ocampo ON. Am Heart J; 1999 Aug; 138(2 Pt 1):261-8. PubMed ID: 10426837 [Abstract] [Full Text] [Related]
35. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D, Wolfel EE, Lindenfeld J, Tsvetkova T, Robertson AD, Quaife RA, Bristow MR. N Engl J Med; 2002 May 02; 346(18):1357-65. PubMed ID: 11986409 [Abstract] [Full Text] [Related]
36. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy. Nikolaidis LA, Poornima I, Parikh P, Magovern M, Shen YT, Shannon RP. J Am Coll Cardiol; 2006 May 02; 47(9):1871-81. PubMed ID: 16682315 [Abstract] [Full Text] [Related]
37. Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy. Griffin BP, Shah PK, Ferguson J, Rubin SA. Am J Cardiol; 1991 Apr 15; 67(9):848-53. PubMed ID: 1901438 [Abstract] [Full Text] [Related]
38. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ. J Am Coll Cardiol; 1995 Apr 15; 25(5):1154-61. PubMed ID: 7897129 [Abstract] [Full Text] [Related]
39. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment. Braun M, Edelmann F, Knapp M, Schön S, Schwencke C, Simonis G, Borst M, Weinbrenner C, Strasser RH. Int J Cardiol; 2009 Feb 20; 132(2):248-56. PubMed ID: 18579230 [Abstract] [Full Text] [Related]
40. Effect of acute hemodynamic decompensation on electrical inducibility of ventricular arrhythmias in patients with dilated cardiomyopathy and complex nonsustained ventricular arrhythmias. Kulick DL, Bhandari AK, Hong R, Petersen R, Leon C, Rahimtoola SH. Am Heart J; 1990 Apr 20; 119(4):878-83. PubMed ID: 2321507 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]